SOURCES SOUGHT
66 -- Brand Name or Equal Illumina Neo Prep Library System
- Notice Date
- 12/3/2015
- Notice Type
- Sources Sought
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Rockville, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001, United States
- ZIP Code
- 20857-0001
- Solicitation Number
- SourcesSought-1159321
- Archive Date
- 12/25/2015
- Point of Contact
- Howard S. Yablon, Phone: 2404027630
- E-Mail Address
-
howard.yablon@fda.hhs.gov
(howard.yablon@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Sources Sought: Small Business This is a Small Business Sources Sought notice. This is not a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified small business sources; (2) whether they are small business; HUBZone small businesses; service-disabled veteran owned small businesses; 8(a) or small disadvantaged businesses; women-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North America Industry Classification System (NAICS) code for the proposed acquisition (334516, Analytical Laboratory Instrument Manufacturing Size Standard: 500 employees). Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. An organization is not considered a small business under the applicable NAICS code should not submit a response to this notice. PURPOSE AND OBJECTIVES The purpose and objectives of this potential requirement is to procure one (1) brand name or equal Illumina Neo Library Prep Library System with four (4) one year service maintenance option years that is compatible with existing Illumina brand sequencing systems and specific reagent kits to be delivered, installed at our facility in Laurel, Maryland 20708 (See Salient Characteristics section below for existing Illumina brand sequencing systems and specific reagent kits needed). Salient Characteristics of Library Preparation System •Must be a new system, not used or refurbished •Instrument must be a fully-integrated, closed (self-contained) system allowing for hands off functionality (minimum manual labor or in-person attention required to process a sample through the library preparation for the next-generation sequencing workflow). Instrument must be able to perform all library preparation steps, including PCR amplification quantification, and normalization using a simple workflow (a workflow where there is minimal manual intervention required to go through a library preparation steps), Instrument shall not require additional dedicated PCR amplification system or equipment for amplification. •The instrument must come with all auxiliary equipment necessary to make it fully functional. •Instrument must be able to perform bead base normalization (Steps where beads are used to bind and purify DNA). •Libraries prepared with the system must meet requirements for Illumina sequencing system including the MiSeq, NextSeq 400 and HiSeq •Capable of generating at least 16 libraries during the same run. •Capable of processing TruSeq Nano DNA and TruSeq Stranded mRNA library preparation kits based on compatibility with existing equipment. •Reagents: System must include two (2) sets of reagents for installation/optimization and testing. TruSeq nano DNA kit- Quantity 2 TruSeq Stranded nRNA library preparation kits- Quantity 2 •Delivery and Installation Criteria Deliver and install system and ensure that the system is synchronized perfectly with the existing LaVision PIV system (both hardware and software Training: On-site familiarization training for multiple users. This training session will take place at the FDA location. •Warranty: One year warranty for parts and labor, telephone and email support, with 4 (four), one year service maintenance option years Anticipated Period Of Performance •Delivery, Installation, and Training: 30 days after award or approx. date: 2/15/2016 •Warranty Period: 2/15/-2016-2/14/2017 •Option Year 1, Service Maintenance Agreement: 2/15/2017-2/14/2018 •Option Year 2, Service Maintenance Agreement: 2/15/2018-2/14/2019 •Option Year 3, Service Maintenance Agreement: 2/15/2019-2/14/2020 •Option Year 4, Service Maintenance Agreement: 2/15/2020-2/14/2021 CAPABILITY STATEMENT/INFORMATION SOUGHT The FDA is requesting interested qualified small businesses to provide a capability statement showing their ability and willingness to complete this requirement electronically to Howard Yablon at howard.yablon@fda.hhs.gov in a commonly used format such as Microsoft Word or pdf. The capability statement shall be no more than five pages long excluding the cover page and table of contents. The FDA will be determining capability based on the ability to supply the above scientific instrument as delineated above. Interested eligible small businesses shall also include company information to determine eligibility, including their contact information, DUNS number and size and business type (e.g. 8(a), HUBZONE, etc.) based on the applicable NAICS code for the proposed acquisition, (334516, Analytical Laboratory Instrument Manufacturing Size Standard: 500 employees). Potential offerors have until 3:00 PM ET, Thursday, December 10, 2015 to respond to the FDA. DISCLAIMER AND IMPORTANT NOTES This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of any information received or provide feedback to respondents with respect to any information submitted. After a review of the responses received, a combined synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate responses to a solicitation. CONFIDENTIALITY No propriety, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s).
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/SourcesSought-1159321/listing.html)
- Record
- SN03960319-W 20151205/151203234712-239b47fdf314e5cb16d0edfbe110c9bd (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |